Literature DB >> 8702986

Stability and oligomeric equilibria of refolded interleukin-1beta converting enzyme.

R V Talanian1, L C Dang, C R Ferenz, M C Hackett, J A Mankovich, J P Welch, W W Wong, K D Brady.   

Abstract

We report the preparation and characterization of interleukin-1beta converting enzyme (ICE) refolded from its p20 and p10 protein fragments. Refolded ICE heterodimer (p20p10) was catalytically active but unstable, and in size exclusion chromatography eluted at an apparent molecular mass of 30 kDa. The mechanisms of the observed instability were pH-dependent dissociation at low enzyme concentrations, and autolytic degradation of the p10 subunit at high concentrations. Binding and subsequent removal of a high affinity peptidic inhibitor increased the apparent molecular mass to 43 kDa (by size exclusion chromatography), and significantly increased its stability and specific activity. Chemical cross-linking and SDS-polyacrylamide gel electrophoresis analysis of the 43-kDa size exclusion chromatography conformer revealed a 60-kDa species, which was absent in the 30-kDa conformer, suggesting that inhibitor binding caused formation of a (p20p10)2 homodimer. The observation of a reversible equilibrium between ICE (p20p10) and (p20p10)2 suggests that analogous associations, possibly between ICE and ICE homologs, can occur in vivo, resulting in novel oligomeric protease species.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702986     DOI: 10.1074/jbc.271.36.21853

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Dimer formation drives the activation of the cell death protease caspase 9.

Authors:  M Renatus; H R Stennicke; F L Scott; R C Liddington; G S Salvesen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

3.  Molecular dynamics studies of caspase-3.

Authors:  M Sulpizi; U Rothlisberger; P Carloni
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

4.  Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9.

Authors:  R R Annand; J R Dahlen; C A Sprecher; P De Dreu; D C Foster; J A Mankovich; R V Talanian; W Kisiel; D A Giegel
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3.

Authors:  Debajyoti Datta; Christopher L McClendon; Matthew P Jacobson; James A Wells
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

6.  Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.

Authors:  Kristiina Rajamäki; Tommy Nordström; Katariina Nurmi; Karl E O Åkerman; Petri T Kovanen; Katariina Öörni; Kari K Eklund
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

7.  Ionic interactions near the loop L4 are important for maintaining the active-site environment and the dimer stability of (pro)caspase 3.

Authors:  Brett Feeney; Cristina Pop; Ashutosh Tripathy; A Clay Clark
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

8.  A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases.

Authors:  Kevin Dagbay; Scott J Eron; Banyuhay P Serrano; Elih M Velázquez-Delgado; Yunlong Zhao; Di Lin; Sravanti Vaidya; Jeanne A Hardy
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 9.  The intricate biophysical puzzle of caspase-1 activation.

Authors:  Nyasha J Makoni; Michael R Nichols
Journal:  Arch Biochem Biophys       Date:  2021-01-13       Impact factor: 4.013

10.  Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme.

Authors:  John G Walsh; Susan E Logue; Alexander U Lüthi; Seamus J Martin
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.